Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Breakthrough rectal cancer therapy could spare patients from permanent colostomy

NCT ID NCT07068763

Recruiting now Disease control Sponsor: Sir Run Run Shaw Hospital Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 19 times

Summary

This study tests a new approach for people with early-stage rectal cancer that hasn't spread to lymph nodes. Instead of standard radiation to the whole pelvis, doctors give a short course of radiation only to the tumor, followed by chemotherapy and two types of immunotherapy. The goal is to shrink the cancer enough so that some patients may not need surgery at all, preserving the rectum and avoiding a permanent colostomy bag. About 52 adults with a specific genetic type (MSS) will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sir run run shaw hospital

    RECRUITING

    Hangzhou, Zhejiang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

RECTAL CANCER